Get access to our best features

Get access to our best features

Merck COVID-19 pill linked to virus mutations – study (NYSE:MRK)

Summary by Ground News
Lagevrio, the FDA-authorized oral COVID-19 therapy, leads to new mutations in the virus, according to a new study. The researchers in the U.S. and U.K. collaborated with those in the Francis Crick Institute, Imperial College, and the University of Liverpool.
Published 4 months ago

News Articles

More
Filters
All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Bloomberg
South China Morning Post
Seeking Alpha
L 33%
C 34%
R 33%
See less detail